Rare diseases
Investigational molecules
Locations
Back to Poland337 clinical trials in Rzeszow, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis
PolandStudy of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis
PolandStudy of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid
PolandStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
PolandStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa
PolandStudy on the Safety and Effectiveness of Durvalumab, Paclitaxel, and Drug Combinations for Patients with Metastatic Triple Negative Breast Cancer
PolandStudy on the Effects of Barzolvolimab for Patients with Prurigo Nodularis
PolandStudy on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
PolandStudy on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PolandStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
PolandStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
PolandStudy on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focusing on innovative treatments for inflammatory bowel diseases and autoimmune conditions, including studies on new therapies for ulcerative colitis and Crohn's disease.
Multiple trials evaluating novel compounds and biological therapies for inflammatory conditions.
Studies investigating treatments for heart failure prevention and metabolic disorders, with emphasis on innovative therapeutic approaches for obesity and cardiovascular health.
Focus on combination therapies and novel compounds for cardiometabolic conditions.
Clinical investigations targeting multiple sclerosis and chronic inflammatory conditions affecting the nervous system.
Evaluation of new therapeutic agents for managing neurological and immune-mediated conditions.
Research on various specialized conditions including geographic atrophy and reproductive health treatments.
Diverse studies focusing on improving patient outcomes across multiple therapeutic areas.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
